Skip to Content

Pazeo Approval History

  • FDA approved: Yes (First approved January 30th, 2015)
  • Brand name: Pazeo
  • Generic name: olopatadine hydrochloride
  • Dosage form: Ophthalmic Solution
  • Company: Alcon
  • Treatment for: Conjunctivitis, Allergic

Pazeo (olopatadine hydrochloride) is a mast cell stabilizer for the treatment of ocular itching associated with allergic conjunctivitis.

Development History and FDA Approval Process for Pazeo

Feb  2, 2015Approval Alcon Receives FDA Approval of Pazeo (olopatadine HCl) Ophthalmic Solution for Allergic Conjunctivitis

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.